Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.

Anticancer research - 1 Jan 2000

Chuang Cheng-Keng, Liao Shuen-Kuei

Abstract excerpt

BACKGROUND: Certain splice variants (CD44v) can promote the progressive and metastatic behavior of cancer. We tested whether different CD44v molecules were selectively expressed in transitional cell carcinomas based on the stage and grade. MATERIALS AND METHODS: A panel of 13 TCC cell lines with different degrees of differentiation and biological behavior were tested with monoclonal antibodies to CD44s, CD44v5,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Antigens, CD
Share to Carcinoma, Transitional Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Hyaluronan Receptors

Share to Neoplasm Staging

Share to Recurrence

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 14981907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.PMID 14981907Read ↗

Expression and modulation of CD44 variant isoforms in humansSemantic proximity Read ↗

Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.Semantic proximity Read ↗

Current status of CD44 variant isoforms as cancer diagnostic markers.Semantic proximity Read ↗

CD44v6 Promotes Proliferation, Migration, and Invasion in Cholangiocarcinoma Cells, but Lacks Independent Prognostic SignificanceSemantic proximity Read ↗

Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma, micropapillary variant.Semantic proximity Read ↗

Prognostic value of CD44 splice variants in human stage III cervical cancerSemantic proximity Read ↗

Characterization of CD44 variant expression in head and neck squamous cell carcinomasSemantic proximity Read ↗

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.Semantic proximity Read ↗

A Novel Anti-CD44 Variant 9 Monoclonal Antibody C<sub>44</sub>Mab-1 was Developed for Immunohistochemical Analyses Against Colorectal CancersSemantic proximity Read ↗

Expression of CD44 splice variants during lymphocyte activation and tumor progression.Semantic proximity Read ↗

[Occurrence of CD44 and its isoforms under orthological and pathological conditions].Semantic proximity Read ↗

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.